Sanofi Hit By Ge
LONDON (Reuters) - French drugmaker Sanofi-Aventis
<SASY.PA>, which briefly encountered generic competition to its
second-biggest product Plavix in the United States in 2006 and
2007, now faces a similar threat in Europe.
LONDON (Reuters) - French drugmaker Sanofi-Aventis
<SASY.PA>, which briefly encountered generic competition to its
second-biggest product Plavix in the United States in 2006 and
2007, now faces a similar threat in Europe.
Similar/Related/News: